PYC.AX
Price:
$1.28
Market Cap:
$597.26M
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was...[Read more]
Industry
Biotechnology
IPO Date
2005-03-30
Stock Exchange
ASX
Ticker
PYC.AX
According to PYC Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -12.80. This represents a change of -77.57% compared to the average of -57.07 of the last 4 quarters.
The mean historical PE Ratio of PYC Therapeutics Limited over the last ten years is -219.89. The current -12.80 PE Ratio has changed 482.11% with respect to the historical average. Over the past ten years (40 quarters), PYC.AX's PE Ratio was at its highest in in the June 2013 quarter at -7.58. The PE Ratio was at its lowest in in the January 2010 quarter at -498.66.
Average
-219.89
Median
-156.45
Minimum
-610.33
Maximum
-63.24
Discovering the peaks and valleys of PYC Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 865.15%
Maximum Annual PE Ratio = -63.24
Minimum Annual Increase = -87.41%
Minimum Annual PE Ratio = -610.33
Year | PE Ratio | Change |
---|---|---|
2024 | -125.00 | 56.57% |
2023 | -79.83 | -47.10% |
2022 | -150.92 | -44.70% |
2021 | -272.92 | -41.66% |
2020 | -467.80 | 146.16% |
2019 | -190.04 | 147.32% |
2018 | -76.84 | -87.41% |
2017 | -610.33 | 865.15% |
2016 | -63.24 | -60.96% |
2015 | -161.98 | 90.57% |
The current PE Ratio of PYC Therapeutics Limited (PYC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-118.58
5-year avg
-219.29
10-year avg
-219.89
PYC Therapeutics Limited’s PE Ratio is less than Pharmaxis Ltd (-2.15), less than Neuren Pharmaceuticals Limited (12.96), less than Patrys Limited (-1.74), greater than PharmAust Limited (-13.32), less than Antisense Therapeutics Limited (0),
Company | PE Ratio | Market cap |
---|---|---|
-2.15 | $20.23M | |
12.96 | $1.52B | |
-1.74 | $6.17M | |
-13.32 | $111.93M | |
0 | $52.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PYC Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PYC Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PYC Therapeutics Limited's PE Ratio?
How is the PE Ratio calculated for PYC Therapeutics Limited (PYC.AX)?
What is the highest PE Ratio for PYC Therapeutics Limited (PYC.AX)?
What is the 3-year average PE Ratio for PYC Therapeutics Limited (PYC.AX)?
What is the 5-year average PE Ratio for PYC Therapeutics Limited (PYC.AX)?
How does the current PE Ratio for PYC Therapeutics Limited (PYC.AX) compare to its historical average?